We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





AI Algorithm Combines CT Images with Non-Imaging Data to Accurately Predict COVID-19 Patient Outcomes

By HospiMedica International staff writers
Posted on 24 Nov 2020
Print article
Illustration
Illustration
A team of engineers at the Rensselaer Polytechnic Institute (Troy, NY, USA) has demonstrated how a new algorithm they developed was able to successfully predict whether or not a COVID-19 patient would need ICU intervention.

With communities across the nation experiencing a wave of COVID-19 infections, clinicians need effective tools that will enable them to aggressively and accurately treat each patient based on their specific disease presentation, health history, and medical risks. The artificial intelligence-based approach could be a valuable tool in determining a proper course of treatment for individual patients.

The research team developed this method by combining chest computed tomography (CT) images that assess the severity of a patient’s lung infection with non-imaging data, such as demographic information, vital signs, and laboratory blood test results. By combining these data points, the algorithm is able to predict patient outcomes, specifically whether or not a patient will need ICU intervention. The algorithm was tested on datasets collected from a total of 295 patients from three different hospitals - one in the US, one in Iran, and one in Italy. Researchers were able to compare the algorithm’s predictions to what kind of treatment a patient actually ended up needing. The researchers will now integrate their new algorithm with another developed previously to assess a patient’s risk of cardiovascular disease using chest CT scans.

“We know that a key factor in COVID mortality is whether a patient has underlying conditions and heart disease is a significant comorbidity,” said Pingkun Yan, an assistant professor of biomedical engineering at Rensselaer Polytechnic Institute who led the research team. “How much this contributes to their disease progress is, right now, fairly subjective. So, we have to have a quantification of their heart condition and then determine how we factor that into this prediction.”

Related Links:
Rensselaer Polytechnic Institute

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.